Generic Name and Formulations:
Fexofenadine HCl 60mg, 180mg; tabs.
Indications for ALLEGRA:
Allergic rhinitis (seasonal). Chronic idiopathic urticaria.
180mg once daily or 60mg twice daily. Renal impairment: initially 60mg once daily.
Use Children's Allegra.
Pregnancy (Cat.C). Nursing mothers.
Avoid concomitant aluminum- or magnesium-containing antacids.
Adults: Headache, back pain, viral infection, GI upset, sinusitis, dizziness, drowsiness. Children: cough, fever, pain, otitis media, upper respiratory tract infection.
Tabs 60mg—12; 180mg—5, 30, 45, 70
Clinical Pain Advisor Articles
- Risks Associated With Co-Administration of Aspirin and Other NSAIDs
- Stages of Low Back Pain Have Specific Sets of Clinical Indicators
- FDA Approves Aimovig for Migraine Prevention
- First Non-Opioid Drug Approved for Managing Opioid Withdrawal Symptoms
- Pain Interference Associated With Depression, Pain Self-Efficacy in Chronic Musculoskeletal Pain
- Effect of Prescription Drug Monitoring Programs on Fatal, Nonfatal Drug Overdoses
- Standardized SCS Workflow May Effectively Alleviate Failed Back Surgery Syndrome-Related Pain
- Marijuana Legalization and Opioid Prescribing Rates
- Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes
- Interbrain Coupling During Handholding Associated With Analgesia, Empathy
- Remission Rates and Predictors of Chronic Headache
- Overuse and Underuse of Imaging Common in Low Back Pain Management
- Unit-Dose Packaging of Buprenorphine-Naloxone Effective on Unintentional Pediatric Exposure
- Language Used in Medical Record Can Affect Patient Care
- Opioid-Related Adverse Drug Events Associated With Worse Patient, Cost Outcomes